If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
109.00    0.80 (0.74%)
Bid:
108.80
Ask:
109.00
Spread: 0.20 (0.184%)
Market Cap: £458.19m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Q3 TRADING UPDATE

24 Mar 2026 07:00

RNS Number : 7795X
PZ CUSSONS PLC
24 March 2026
 

24 March 2026

Q3 TRADING UPDATE

 

Continued strong trading

Full year profit expected to be at upper end of guidance

 

PZ Cussons plc ("PZ Cussons" or the "Group") today issues a trading update for its third quarter, ended 28 February 2026.

 

The positive trading momentum in the first half of the year has continued, with 6.3% Group LFL revenue growth in Q3 (H1 FY26: 9.5%). On a reported basis, revenue growth was 5.0% (H1 FY26: 8.0%).

 

Reflecting the performance to date, with further stability in the Nigerian Naira and careful cost management, the Group now expects to report adjusted operating profit towards the upper end of the previously updated £53-57 million guidance range.

 

While this guidance remains subject to movements in the Nigerian Naira in the remaining weeks of the financial year, the actions management have taken to mitigate against future volatility have continued to reduce the Group's sensitivity to such fluctuations.

The Group will report FY26 results on 6 August 2026.

 

 

Contact details

 

Investors 

Simon Whittington - IR and Corporate Development Director

+44 (0) 77 1137 2928

Media

Headland PZCussons@headlandconsultancy.com

+44 (0) 20 3805 4822

Susanna Voyle, Charlie Twigg

 

Notes to Editors

Unless otherwise stated, all references to revenue growth are on a like for like ('LFL') basis. See definitions provided in the interim results announcement for further details. Figures presented in this announcement are unaudited.

 

About PZ Cussons

 

PZ Cussons is a listed consumer goods business headquartered in Manchester, UK, employing just under 2,500 people internationally. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. We are focused on our lead markets of the UK, ANZ, Nigeria and Indonesia across the core categories of Personal, Home and Baby Care. Our locally-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa, Stella and St.Tropez. Sustainability and the wellbeing of our employees and communities everywhere are core to what we do and captured by our purpose: For everyone, for life, for good.

 

Cautionary note regarding forward-looking statements

 

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward-looking statements contained within this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOOARNOUOUUR
Date   Source Headline
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement
20th Nov 20241:36 pmRNSDirector/PDMR Shareholding
21st Oct 20249:21 amRNSDirector/PDMR Shareholding
27th Sep 20241:16 pmRNSDirector/PDMR Shareholding
27th Sep 20241:11 pmRNSDirector/PDMR Shareholding
26th Sep 20244:09 pmRNSPublication of Annual Report and Notice of AGM
25th Sep 20245:48 pmRNSDirector/PDMR Shareholding
25th Sep 202410:40 amRNSDirector Declaration
19th Sep 20245:36 pmRNSDirector/PDMR Shareholding
18th Sep 20247:22 amRNSBoard Change
21st Aug 20244:29 pmRNSDirector/PDMR Shareholding
25th Jul 202411:10 amRNSDirector/PDMR Shareholding
19th Jul 20245:31 pmRNSDirector/PDMR Shareholding
26th Jun 20247:00 amRNSTrading Statement
25th Jun 20249:39 amRNSDirector/PDMR Shareholding
20th May 202411:52 amRNSDirector/PDMR Shareholding
10th May 202410:00 amRNS2023 AGM Voting Results Update Statement
24th Apr 20247:00 amRNSQ3 Trading and update on strategic actions
19th Apr 20248:49 amRNSDirector/PDMR Shareholding
12th Apr 202411:04 amRNSDirector/PDMR Shareholding
8th Apr 20245:29 pmRNSDirector/PDMR Shareholding
19th Mar 202410:30 amRNSDirector/PDMR Shareholding
23rd Feb 20243:47 pmRNSDirector/PDMR Shareholding
19th Feb 20243:18 pmRNSDirector/PDMR Shareholding
8th Feb 20243:40 pmRNSDirector/PDMR Shareholding
8th Feb 20243:09 pmRNSDirector/PDMR Shareholding
8th Feb 20243:07 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNS2024 Interim Results
19th Jan 202410:50 amRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSDirectorate Change
18th Dec 20233:10 pmRNSDirector/PDMR Shareholding
4th Dec 20233:03 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirectorate Change
29th Nov 202312:10 pmRNSDirector/PDMR Shareholding
29th Nov 202312:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20235:57 pmRNSResult of AGM
23rd Nov 20237:00 amRNSAGM Trading Statement
20th Nov 20231:58 pmRNSDirector/PDMR Shareholding
19th Oct 202310:00 amRNSDirector/PDMR Shareholding
10th Oct 202311:10 amRNSDirector/PDMR Shareholding
5th Oct 20233:44 pmRNSHolding(s) in Company
27th Sep 202310:00 amRNSPreliminary Results - Correction
26th Sep 20237:00 amRNSPZ Cussons Preliminary Results
20th Sep 202311:09 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSAcquisition of minority ownership of PZCN Plc
21st Aug 20232:07 pmRNSDirector/PDMR Shareholding
26th Jul 20239:22 amRNSDirector/PDMR Shareholding
19th Jul 202310:23 amRNSDirector/PDMR Shareholding
11th Jul 20232:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.